A global survey of health professionals, led by Queen Mary University of London, has shown that during the COVID-19 pandemic, patients with Parkinson's disease in large parts of Asia, Africa, and Latin and South America experienced ...
Sep 21, 2020
0
4
A new study led by Boston Medical Center researchers indicates a well-known biomarker that serves as a marker for earlier diagnosis of neurodegenerative diseases is now detectable in the eye. Neurofilament light chain, a ...
Sep 21, 2020
0
5
Including genetic markers in addition to well known risk factors improves tests to predict Parkinson's disease, according to a study led by Queen Mary University of London.
Sep 16, 2020
0
4
Freezing of gait, one of the most incapacitating symptoms of Parkinson's disease, manifests as sudden, short episodes of an inability to move the feet forward despite the intention to walk. Researchers at the University of ...
Sep 15, 2020
0
198
In a recently published study, researchers from the Turku Bioscience Center at the University of Turku and Åbo Akademi University in Finland monitored the production of new proteins as they were produced by the cells' protein ...
Sep 15, 2020
0
3
A major clinical trial of a potential new treatment for Parkinson's disease (PD) has found that the statin under investigation holds no promise as a protective therapy in PD.
Sep 14, 2020
0
5
A new study using induced pluripotent stem cell (iPSC) technology links astrocyte dysfunction to Parkinson's disease (PD) pathology. The study carried out at the University of Eastern Finland and published in Scientific Reports ...
Sep 7, 2020
0
190
A versatile probe that can detect with pinpoint accuracy the programmed destruction of defective mitochondria—the powerhouses of cells—has been developed by RIKEN researchers. They used it to show that damaged mitochondria ...
Aug 14, 2020
0
128
A review of currently registered clinical trials of agents targeting Parkinson's disease (PD) reveals that there is a broad pipeline of both symptomatic and potentially disease-modifying therapies currently being evaluated. ...
Aug 3, 2020
0
6
Timely administration of anti-Parkinson drugs is a significant issue for hospitalized patients with Parkinson's disease (PD) with late or missed doses resulting in longer stays and worse outcomes. As part of a quality improvement ...
Jul 9, 2020
0
3
